Finding the right cancer drug for each patient.
Late-stage cancer doctors lack data-driven tools to choose the most effective existing targeted drug for an individual patient’s specific tumor biology.
Oncobox provides low-cost personalized genetic profiling and analytics to match a patient’s cancer to the targeted therapies most likely to work.
Oncologists and hospitals treating late-stage cancer patients use it to guide targeted therapy selection.




